System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Ibrahim Oluwatobi Kehinde is an expert in Biochemistry at University of KwaZulu-Natal (South Africa). Ibrahim Oluwatobi Kehinde has authored 12 publications, the most recent in 2026. SLR score: 39 (community average: 125). How the SLR is computed.

LeadR Profile

Ibrahim Oluwatobi Kehinde University of KwaZulu-Natal South Africa
39 ScienceLeadR Reputation 39

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Pharmacy - Oncology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2019 - 2026
Source: PubMed

University of KwaZulu-Natal

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 12

Citations

Citations: 15 1st author: 4 Last author: 0 Unique author: 0

Main journals

Cell Biochem Biophys 3
J Cell Biochem 2
Chem Biodivers 1
Comput Biol Chem 1
Deleted Journal 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Towards macrophage-oriented Antituberculosis therapy: nanohydrogel and liposomal delivery of rifampicin-berberine Co-nanocrystals for enhanced intracellular Antituberculosis activity.
PMID 42612927 — pharmaceutical preparations, liposomes, macrophages, tuberculosis, therapeutics, berberine, rifampin		Eur J Pharm Biopharm20260
Investigation of the Anticancer Potential of Thai Blue Sponge via Targeting the PI3K/AKT/SRC Signaling Pathway using Molecular Docking and Dynamic Stimulation.
PMID 41941051 — genes, src		Cell Biochem Biophys20260
Ginsenoside Rb1 as a multi-target modulator in heart failure: Mechanistic insights into extracellular remodeling and transcriptional pathways from network pharmacology, molecular dynamics, and binding free energy analyses.
PMID 41579555 — heart failure, pharmaceutical preparations, heart, multiple chronic conditions, ginsenosides, pharmacology		Comput Biol Chem20261
Targeting the TRIM28-EZH2 Protein-Protein Interface With Cysteine-Reactive Covalent Inhibitors: A Computational Blueprint for Cancer Therapy.
PMID 41504013 — genes, cysteine, biochemistry, neoplasms, therapeutics		Chem Biodivers20260
A Computational Approach for Designing a Peptide-Based Acetyl-CoA Synthetase 2 Inhibitor: A New Horizon for Anticancer Development.
PMID 40287570 — ligases, acetyl coenzyme a, coenzyme a, biophysics, pharmaceutical preparations, acetate-coa ligase, therapeutics		Cell Biochem Biophys20250

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS